Skip to main content

Skin Substitution Products is the largest segment driving the growth of U.S. Acellular Dermal Matrices Market

U.S. Acellular Dermal Matrices Market

The global U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2783.32 Mn or Mn in 2023 and is expected to exhibit a CAGR of 3.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Acellular dermal matrices are used in tissue regeneration as skin substitutes. They are derived from human or animal dermis tissues and are used routinely in plastic and reconstructive surgeries.

Market key trends:-

One of the key trends in the U.S. acellular dermal matrices market is the growing demand for advanced wound care products. With rising incidences of diabetic foot ulcers and pressure ulcers, there is increasing demand for acellular dermal matrices for wound closure and healing. These dermal matrices help regenerate tissue and promotes wound healing. Additionally, technologically advanced acellular matrices that mimic natural extracellular matrix are gaining traction. Products infused with growth factors or cells expedite wound healing.

Market key trends:-

The U.S. acellular dermal matrices market has been witnessing high growth over the past few years. One of the key trends driving the growth of this market is the increasing use of acellular dermal matrices for hernia repair surgeries. Acellular dermal matrices are widely used in hernia repair procedures due to their ability to reinforce and strengthen weak tissue areas. Moreover, with rising geriatric population and increasing incidence of hernias, the demand for hernia repair surgeries using acellular dermal matrices is expected to rise in the country.

SWOT Analysis

  • Strength: Acellular dermal matrices offer effective tissue reinforcement and reduce postoperative hernia recurrence rates. They help integrate well with the native tissue.
  • Weakness: High costs associated with acellular dermal matrices can limit their adoption.
  • Opportunity: Growing geriatric population prone to hernias creates growth opportunities. Increasing awareness about benefits of acellular dermal matrices also presents opportunities.
  • Threats: Stringent regulatory approvals and recalls of dermal matrix products pose threats. Reimbursement issues also restrict market growth.

Key Takeaways:-

The U.S. Acellular Dermal Matrices Market Size was valued at US$ 2783.32 Mn in 2023 and is expanding at a CAGR of 3.8% during the forecast period.

The rising incidence of hernias coupled with the growing geriatric population in the U.S. is a major factor driving the demand for acellular dermal matrices in the country. According to the National Center for Biotechnology Information (NCBI), groin hernias account for 75% of all hernias in the U.S., with over 1 million repairs done every year.

Regionally, the South region dominated the U.S. acellular dermal matrices market in 2023 and is expected to continue its dominance over the forecast period. This is attributed to the presence of major market players andavailability of advanced healthcare facilities in states such as Florida, Texas and North Carolina.

Key players operating in the U.S. Acellular Dermal Matrices market are Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, Marine Polymer Technologies, Inc.

 

Read More - https://www.insightprobing.com/u-s-acellular-dermal-matrices-market-forecasts-and-outlook-analysis/

Labels:

Comments

Post a Comment

Popular posts from this blog

Future Prospects of the Plastic Films Market

  Plastic Films Market Market Overview: The plastic films market is estimated to be valued at US$ 98.29 Bn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period (2023-2030) , as highlighted in a new report published by Coherent Market Insights. Plastic films are widely used in various industries such as food and beverage, pharmaceuticals, packaging, and agriculture. These films provide excellent barrier properties, light weight, durability, and flexibility, making them ideal for packaging applications. Moreover, the increasing demand for flexible packaging solutions, especially in the food and beverage industry, is driving the growth of the plastic films market. The rise in population, changing consumer preferences, and the growth of e-commerce have further contributed to the market growth. Market Dynamics: The plastic films market is driven by two key factors: increasing demand for sustainable packaging solutions and technological advancements in plastic fil
Post a Comment
Read more

Growth of Thin Film Solar Cell Market

Thin Film Solar Cell Market The global Thin Film Solar Cell Market is estimated to be valued at US$ 39.41 Bn or Mn in 2023 and is expected to exhibit a CAGR of 19% over the forecast period 2023 to 2030 , as highlighted in a new report published by Coherent Market Insights. Market Overview: - Thin film solar cells are thin layers of photovoltaic material deposited or grown onto a substrate such as glass, plastic or metal. They are more efficient than traditional silicon-based solar panels and are lightweight and flexible. Their advantages include low material usage, simple manufacturing process and flexibility in design. Market key trends: - One of the key trends in the thin film solar cell market is the development of Cadmium Telluride (CdTe) thin film technology. CdTe thin film solar modules offer higher conversion efficiencies compared to other thin film technologies such as Amorphous Silicon and CIGS. Research is ongoing to further enhance the efficiencies of CdTe thin film solar p
Post a Comment
Read more

Advancements and Challenges in the Global Market for Hereditary Orotic Aciduria

Hereditary Orotic Aciduria Market Hereditary Orotic Aciduria (HOA) is a rare genetic disorder characterized by a deficiency of the enzyme uridine monophosphate synthase (UMPS), which is involved in the synthesis of pyrimidine nucleotides. This disorder leads to the accumulation of orotic acid in the urine and plasma, causing severe complications such as anemia, failure to thrive, developmental delays, and neurologic abnormalities. The global market for Hereditary Orotic Aciduria is witnessing steady growth, primarily driven by advancements in diagnostic techniques, increased awareness among healthcare professionals, and growing research and development activities aimed at finding effective treatments for this rare disorder. However, due to its low prevalence rate and lack of awareness among the general population, the market still faces challenges in terms of access to diagnosis and treatment options. The Global  Hereditary Orotic Aciduria  Size is estimated to be valued at  US$ 3
Post a Comment
Read more